Tuesday, 15 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14389
Articles
Company
Drug
Hualan Biological’s HL08 GLP-1 Drug Gets NMPA Nod for Obesity Trial
February 4, 2026
Company
Deals
Bio-Thera Licenses Keytruda Biosimilar BAT3306 to Avalon for Middle East & North Africa
February 4, 2026
Company
Drug
Marubeni Launches Xenleta in China After Complex Licensing Journey
February 4, 2026
Company
Drug
CMS-D017 Gets NMPA Approval for Complement-Mediated Kidney Disease Study
February 4, 2026
Company
Deals
Akeso Licenses Yixining to Jumpcan for PCSK9 Promotion in China
February 4, 2026
Company
Drug
United Laboratories UBT251 Gets NMPA Nod for Sleep Apnea Trial
February 4, 2026
Company
Drug
Wuhan YZY Biopharma Gets FDA Nod for M701 Phase Ib/II MPE Study
February 4, 2026
Company
Amgen Q4 Revenue Grows 9% to $9.9B on Strong Product Sales
February 4, 2026
Company
Deals
Grand Pharmaceutical to Acquire API Firms for RMB 316 Million
February 4, 2026
Company
Novo Nordisk Sales Reach DKK 309 Billion on GLP‑1 and Obesity Surge
February 4, 2026
Company
Deals
Simcere Receives $40M Milestone from AbbVie for Trispecific Myeloma Drug
February 4, 2026
Company
Deals
Medtronic to Acquire CathWorks for $585M, Expand AI-Based FFRangio System
February 4, 2026
1
2
…
167
168
169
170
171
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?